Hemanth J. Varghese, Ph.D., CFA, has been appointed executive vice president of corporate development and strategy at Endo International. Dr. Robert Cobuzzi, who previously served in this role will now serve as senior vice president, U.S. branded pharmaceuticals R&D strategy and operations. Dr. Varghese will report to Rajiv De Silva, Endo’s president and chief executive officer.
 
Dr. Varghese brings corporate development and general management experience in specialty pharmaceuticals, most recently serving as senior vice president and general manager vision care for Bausch & Lomb, a division of Valeant Pharmaceuticals. Dr. Varghese also held senior leadership roles at Valeant, including senior vice president of corporate development and general manager of Valeant’s Neurology & Other business unit.
 
“We are excited to announce the addition of Hemanth to the Endo executive team. His accomplishments and experience in corporate development and integrations will allow us to accelerate the execution of our strategy as we continue to expand our business through value creating acquisitions and partnerships,” said Mr. De Silva. “Hemanth’s track record of success will play a significant role as we execute against our strategy to become a leading specialty healthcare company.”